# Active Surveillance With or Without Apalutamide Treatment in Low Risk Prostate Cancer

> **NCT03088124** · PHASE2 · COMPLETED · sponsor: **Institut Paoli-Calmettes** · enrollment: 93 (actual)

## Conditions studied

- Low Risk Prostate Cancer

## Interventions

- **DRUG:** Apalutamide

## Key facts

- **NCT ID:** NCT03088124
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-28
- **Primary completion:** 2024-10-08
- **Final completion:** 2024-10-08
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2026-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03088124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03088124, "Active Surveillance With or Without Apalutamide Treatment in Low Risk Prostate Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03088124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*